Prostate Stereotactic Body Radiotherapy (SBRT) with the use of RayPilot? prostate tracking system
The first patient with localized adenocarcinoma prostate cancer with Gleason score 7(3+4) and PSA 9ngr/ml, T2NO (PSMA/PET and mpMRI negative for extended or metastatic disease) and IPSS score of 8 before treatment, in AMC (Athens Medical Centre) who’s being treated?with prostate SBRT 3fractions of 9,5Gy each, consecutive days, for a a total dose to the prostate gland of 28.5Gy on Elekta VERSA HD 6D couch correction Linac using the Raypilot catheter technology.
The Raypilot Software is implementing Artificial Intelligence algorithms to reconstruct the localization and any motion.
The Rayilot Hypocath is a temporary urinary catheter with an integrated transmitter. It continuously shows the exact location of the prostate in 3D and outlines the urethra. Knowing precisely where the tumour is located during treatment allows physicians to deliver a higher radiation dose in a fewer number of fractions, with tighter treatment margins that spare healthy tissue from irradiation.
It is an honor and a privilege to participate in Precision Study V4.0 23/5/2023:
The PRECISION Protocol:
A Phase II study of 3 fractions of Prostate SBRT with RayPilot system & HypoCath image guidance for men with NCCN low or intermediate risk prostate cancer